Search Results

There are 29361 results for: content related to: CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction

  1. You have free access to this content
    Effects of clopidogrel and itraconazole on the disposition of efavirenz and its hydroxyl metabolites: exploration of a novel CYP2B6 phenotyping index

    British Journal of Clinical Pharmacology

    Volume 75, Issue 1, January 2013, Pages: 244–253, Fen Jiang, Zeruesenay Desta, Ji-Hong Shon, Chang-Woo Yeo, Ho-Sook Kim, Kwang-Hyeon Liu, Soo-Kyung Bae, Sang-Seop Lee, David A. Flockhart and Jae-Gook Shin

    Version of Record online : 14 DEC 2012, DOI: 10.1111/j.1365-2125.2012.04314.x

  2. Mechanism of Efavirenz Influence on Methadone Pharmacokinetics and Pharmacodynamics

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 4, April 2012, Pages: 673–684, E D Kharasch, D Whittington, D Ensign, C Hoffer, P S Bedynek, S Campbell, K Stubbert, A Crafford, A London and T Kim

    Version of Record online : 7 MAR 2012, DOI: 10.1038/clpt.2011.276

  3. You have free access to this content
    CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects

    British Journal of Clinical Pharmacology

    Volume 80, Issue 2, August 2015, Pages: 276–284, Yibai Li, Kate A. Jackson, Barry Slon, Janet R. Hardy, Michael Franco, Leeroy William, Peter Poon, Janet K. Coller, Mark R. Hutchinson, David C. Currow and Andrew A. Somogyi

    Version of Record online : 1 JUN 2015, DOI: 10.1111/bcp.12614

  4. Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment

    Clinical Pharmacology & Therapeutics

    Volume 78, Issue 6, December 2005, Pages: 593–604, Séverine Crettol, Jean-Jacques Déglon, Jacques Besson, Marina Croquette-Krokkar, Isabelle Gothuey, Robert Hämmig, Martine Monnat, Hardy Hüttemann, Pierre Baumann and Chin B. Eap

    Version of Record online : 7 DEC 2005, DOI: 10.1016/j.clpt.2005.08.011

  5. You have free access to this content
    CYP2B6 983T>C polymorphism is prevalent in West Africa but absent in Papua New Guinea: implications for HIV/AIDS treatment

    British Journal of Clinical Pharmacology

    Volume 64, Issue 3, September 2007, Pages: 391–395, Rajeev K. Mehlotra, Moses J. Bockarie and Peter A. Zimmerman

    Version of Record online : 28 MAR 2007, DOI: 10.1111/j.1365-2125.2007.02884.x

  6. You have free access to this content
    CYP2B6*6 is associated with increased breast cancer risk

    International Journal of Cancer

    Volume 134, Issue 2, 15 January 2014, Pages: 426–430, Christina Justenhoven, Daniela Pentimalli, Sylvia Rabstein, Volker Harth, Anne Lotz, Beate Pesch, Thomas Brüning, Thilo Dörk, Peter Schürmann, Natalia Bogdanova, Tjoung-Won Park-Simon, Fergus J. Couch, Janet E. Olson, Peter A. Fasching, Matthias W. Beckmann, Lothar Häberle, Arif Ekici, Per Hall, Kamilla Czene, Janjun Liu, Jingmei Li, Christian Baisch, Ute Hamann, Yon-Dschun Ko and Hiltrud Brauch

    Version of Record online : 30 JUL 2013, DOI: 10.1002/ijc.28356

  7. You have free access to this content
    Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa

    British Journal of Clinical Pharmacology

    Volume 80, Issue 1, July 2015, Pages: 146–156, Phumla Z. Sinxadi, Paul D. Leger, Helen M. McIlleron, Peter J. Smith, Joel A. Dave, Naomi S Levitt, Gary Maartens and David W. Haas

    Version of Record online : 28 MAY 2015, DOI: 10.1111/bcp.12590

  8. Effect of Rifampicin and CYP2B6 Genotype on Long-Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 3, September 2011, Pages: 406–413, E Ngaimisi, S Mugusi, O Minzi, P Sasi, K-D Riedel, A Suda, N Ueda, M Janabi, F Mugusi, W E Haefeli, L Bertilsson, J Burhenne and E Aklillu

    Version of Record online : 3 AUG 2011, DOI: 10.1038/clpt.2011.129

  9. You have free access to this content
    Rapid clinical induction of bupropion hydroxylation by metamizole in healthy Chinese men

    British Journal of Clinical Pharmacology

    Volume 74, Issue 6, December 2012, Pages: 999–1004, Wen-Jie Qin, Wei Zhang, Zhao-Qian Liu, Xiao-Ping Chen, Zhi-Rong Tan, Dong-Li Hu, Dan Wang, Lan Fan and Hong-Hao Zhou

    Version of Record online : 13 NOV 2012, DOI: 10.1111/j.1365-2125.2012.04304.x

  10. You have free access to this content
    Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity

    British Journal of Clinical Pharmacology

    Volume 79, Issue 6, June 2015, Pages: 967–977, Stéphane Mouly, Vanessa Bloch, Katell Peoc'h, Pascal Houze, Laurence Labat, Kamilia Ksouda, Guy Simoneau, Xavier Declèves, Jean Francois Bergmann, Jean-Michel Scherrmann, Jean-Louis Laplanche, Jean-Pierre Lepine and Florence Vorspan

    Version of Record online : 22 MAY 2015, DOI: 10.1111/bcp.12576

  11. Role of Cytochrome P4502B6 in Methadone Metabolism and Clearance

    The Journal of Clinical Pharmacology

    Volume 53, Issue 3, March 2013, Pages: 305–313, Evan D. Kharasch and Kristi Stubbert

    Version of Record online : 7 JAN 2013, DOI: 10.1002/jcph.1

  12. You have free access to this content
    Current Concepts in Methadone Metabolism and Transport

    Clinical Pharmacology in Drug Development

    Volume 6, Issue 2, March/April 2017, Pages: 125–134, Evan D. Kharasch

    Version of Record online : 6 MAR 2017, DOI: 10.1002/cpdd.326

  13. Long-Term Efavirenz Autoinduction and Its Effect on Plasma Exposure in HIV Patients

    Clinical Pharmacology & Therapeutics

    Volume 88, Issue 5, November 2010, Pages: 676–684, E Ngaimisi, S Mugusi, O M Minzi, P Sasi, K-D Riedel, A Suda, N Ueda, M Janabi, F Mugusi, W E Haefeli, J Burhenne and E Aklillu

    Version of Record online : 29 SEP 2010, DOI: 10.1038/clpt.2010.172

  14. Mechanism of Ritonavir Changes in Methadone Pharmacokinetics and Pharmacodynamics: I. Evidence Against CYP3A Mediation of Methadone Clearance

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 4, October 2008, Pages: 497–505, ED Kharasch, PS Bedynek, S Park, D Whittington, A Walker and C Hoffer

    Version of Record online : 9 JUL 2008, DOI: 10.1038/clpt.2008.104

  15. ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment

    Clinical Pharmacology & Therapeutics

    Volume 80, Issue 6, December 2006, Pages: 668–681, Séverine Crettol, Jean-Jacques Déglon, Jacques Besson, Marina Croquette-Krokar, Robert Hämmig, Isabelle Gothuey, Martine Monnat and Chin B. Eap

    Version of Record online : 15 DEC 2006, DOI: 10.1016/j.clpt.2006.09.012

  16. Pharmacokinetics of Efavirenz When Co-administered With Rifampin in TB/HIV Co-infected Patients: Pharmacogenetic Effect of CYP2B6 Variation

    The Journal of Clinical Pharmacology

    Volume 48, Issue 9, September 2008, Pages: 1032–1040, Dr Awewura Kwara, Dr Margaret Lartey, Mr Kwamena W. Sagoe, Dr Fafa Xexemeku, Dr Ernest Kenu, Dr Joseph Oliver-Commey, Dr Vincent Boima, Mr Augustine Sagoe, Dr Isaac Boamah, Mr David J. Greenblatt and Dr Michael H. Court

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008321790

  17. Efavirenz Inhibits the Human Ether-A-Go-Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B6*6*6 Allele Carriers

    Journal of Cardiovascular Electrophysiology

    Volume 27, Issue 10, October 2016, Pages: 1206–1213, AHMED M. ABDELHADY, TYLER SHUGG, NANCY THONG, JESSICA BO LI LU, YVONNE KREUTZ, HEATHER A. JAYNES, JASON D. ROBARGE, JAMES E. TISDALE, ZERUESENAY DESTA and BRIAN R. OVERHOLSER

    Version of Record online : 25 JUL 2016, DOI: 10.1111/jce.13032

  18. Haplotype structure and allele frequencies of CYP2B6 in Spaniards and Central Americans

    Fundamental & Clinical Pharmacology

    Volume 24, Issue 2, April 2010, Pages: 247–253, Izaskun Arenaz, Jorge Vicente, Ana Fanlo, Patricia Vásquez, Juan Carlos Medina, Blanca Conde, Fabricio González-Andrade and Blanca Sinués

    Version of Record online : 14 AUG 2009, DOI: 10.1111/j.1472-8206.2009.00753.x

  19. You have free access to this content
    Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults

    British Journal of Clinical Pharmacology

    Volume 74, Issue 6, December 2012, Pages: 1005–1012, Chonlaphat Sukasem, Tim R. Cressey, Pattamawan Prapaithong, Yardpiroon Tawon, Ekawat Pasomsub, Chutatip Srichunrusami, Thawinee Jantararoungtong, Marc Lallement and Wasun Chantratita

    Version of Record online : 13 NOV 2012, DOI: 10.1111/j.1365-2125.2012.04288.x

  20. You have free access to this content
    A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans

    British Journal of Clinical Pharmacology

    Volume 68, Issue 5, November 2009, Pages: 690–699, Jackson K. Mukonzo, Daniel Röshammar, Paul Waako, Maria Andersson, Takashi Fukasawa, Lili Milani, Jan Olof Svensson, Jasper Ogwal-Okeng, Lars L. Gustafsson and Eleni Aklillu

    Version of Record online : 7 AUG 2009, DOI: 10.1111/j.1365-2125.2009.03516.x